BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Madera M, Tirado Amador L, Leal Acosta C. Therapeutic Options in Unresectable Oral Squamous Cell Carcinoma: A Systematic Review. Cancer Manag Res 2021;13:6705-19. [PMID: 34471384 DOI: 10.2147/CMAR.S283204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lin CL, Yu CI, Lee TH, Chuang JM, Han KF, Lin CS, Huang WP, Chen JY, Chen CY, Lin MY, Lee CH. Plumbagin induces the apoptosis of drug-resistant oral cancer in vitro and in vivo through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction. Phytomedicine 2023;111:154655. [PMID: 36689858 DOI: 10.1016/j.phymed.2023.154655] [Reference Citation Analysis]
2 Patil S, Yadalam PK, Hosmani J, Khan ZA, Ahmed ZH, Shankar VG, Awan KH. Oral immune-mediated disorders with malignant potential/association: An overview. Dis Mon 2023;69:101349. [PMID: 35337657 DOI: 10.1016/j.disamonth.2022.101349] [Reference Citation Analysis]
3 Katase N, Kudo K, Ogawa K, Sakamoto Y, Nishimatsu SI, Yamauchi A, Fujita S. DKK3/CKAP4 axis is associated with advanced stage and poorer prognosis in oral cancer. Oral Dis 2022. [PMID: 35708905 DOI: 10.1111/odi.14277] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Nocini R, Vianini M, Girolami I, Calabrese L, Scarpa A, Martini M, Morbini P, Marletta S, Brunelli M, Molteni G, Parwani A, Pantanowitz L, Eccher A. PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside. Clin Exp Dent Res 2022. [PMID: 35593124 DOI: 10.1002/cre2.590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]